Xvivo Perfusion AB (publ) (STO:XVIVO)
186.90
+7.60 (4.24%)
At close: Nov 27, 2025
Revenue by Product
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.